Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial-Reference-Cited by-同舟云学术

Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial

Published:2016-02-03 Issue:1 Volume:17 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Tallon Debbie,Wiles Nicola,Campbell John,Chew-Graham Carolyn,Dickens Chris,Macleod Una,Peters Tim J.,Lewis Glyn,Anderson Ian M.,Gilbody Simon,Hollingworth William,Davies Simon,Kessler David

Funder

Health Technology Assessment Programme

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-016-1199-2

Reference51 articles.

1. Mathers C, Loncar D. Updated projections of global mortality and burden of disease, 2002—2030: data sources, methods and results (working paper). Geneva: WHO; 2005.

2. Prescribing and Medicines Team, Health and Social Care Information Centre. Prescriptions dispensed in the community: England 2004—14.2015.

3. Trivedi M, Rush A, Wisniewski S, Nierenberg A, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatr. 2006;163:28–40.

4. National Institute for Clinical Excellence. Clinical Guideline 90. Depression: management of depression in primary and secondary care. London 2009.

5. Connolly K, Thase M. If at first you don’t succeed: a review of evidence for antidepressant augmentation, combination and switching strategies. Drugs. 2011;71(1):43–64.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of serotonin transporter gene polymorphism with efficacy of the antidepressant drugs sertraline and mirtazapine in newly diagnosed patients with major depressive disorders;Human Psychopharmacology: Clinical and Experimental;2022-01-28

2. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT;Health Technology Assessment;2021-11

3. Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial;Journal of Psychopharmacology;2020-11-04

4. Pharmacological interventions for treatment-resistant depression in adults;Cochrane Database of Systematic Reviews;2019-12-17

5. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial;Trials;2019-06-03